Apontis Pharma AG Net Asset Momentum
Apontis Pharma AG net asset momentum. Apontis Pharma AG (APPH) recorded a net asset momentum of 2.5% as of December 2024, with net assets of €31.02 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Apontis Pharma AG reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Apontis Pharma AG (2018–2024)
Net asset momentum of Apontis Pharma AG from 2018 to 2024. This chart tracks Apontis Pharma AG's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +2.5%, with net assets of €31.02 Million EUR as of December 2024. See Apontis Pharma AG book value and equity for net asset value and shareholders' equity analysis.
Apontis Pharma AG Net Asset Momentum by Year (2018–2024)
Apontis Pharma AG net asset momentum by year from 2018 to 2024. The table below shows the complete annual net asset history for Apontis Pharma AG from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see APPH market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €31.02 Million | €44.37 Million | €13.36 Million | ▲ +2.5% |
| 2023 | €30.26 Million | €57.46 Million | €27.20 Million | ▼ -27.2% |
| 2022 | €41.57 Million | €59.85 Million | €18.29 Million | ▲ +2.1% |
| 2021 | €40.71 Million | €54.13 Million | €13.42 Million | ▲ +1077.3% |
| 2020 | €3.46 Million | €29.69 Million | €26.23 Million | ▼ -25.5% |
| 2019 | €4.64 Million | €30.59 Million | €25.94 Million | ▼ -34.0% |
| 2018 | €7.03 Million | €34.84 Million | €27.81 Million | — |